Key result
Amiodarone as second-line therapy converted 5 of 9 (55.6%) hydropic fetuses with supraventricular tachycardia to sinus rhythm after first-line therapy failed.
Why the study?
Does amiodarone improve prenatal conversion to sinus rhythm in hydropic fetuses with supraventricular tachycardia when first-line therapy fails?
Population
26 hydropic fetuses with supraventricular tachycardia
Design
Cohort
Authors
Loading...
May support amiodarone as second-line option in refractory hydropic fetal SVT; hypothesis-generating and requires prospective validation before practice change.
Cohort (n=26)
Does amiodarone improve prenatal conversion to sinus rhythm in hydropic fetuses with supraventricular tachycardia when first-line therapy fails?
Amiodarone is an effective second-line therapy for converting supraventricular tachycardia to sinus rhythm in hydropic fetuses when first-line therapy fails.
Jouannic et al. (2003) conducted a cohort in Hydropic fetuses with supraventricular tachycardia (n=26). Amiodarone was evaluated on Conversion to sinus rhythm. Amiodarone as second-line therapy converted 5 of 9 (55.6%) hydropic fetuses with supraventricular tachycardia to sinus rhythm after first-line therapy failed.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: